Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Harry de Koning

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Geographic Areas

Disorders

Concepts & Ideas

Chemicals & Drugs

Prostate-Specific Antigen

Activities & Behaviors

Physiology

Genetic Predisposition to Disease

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
van den Bergh K A M; Essink-Bot M L; van Klaveren R J; de Koning H J
Informed participation in a randomised controlled trial of computed tomography screening for lung cancer.
Schröder Fritz H; Hugosson Jonas; Roobol Monique J; Tammela Teuvo L J; Ciatto Stefano; Nelen Vera; Kwiatkowski Maciej; Lujan Marcos; Lilja Hans; Zappa Marco; Denis Louis J; Recker Franz; Berenguer Antonio; Määttänen Liisa; Bangma Chris H; Aus Gunnar; Villers Arnauld; Rebillard Xavier; van der Kwast Theodorus; Blijenberg Bert G; Moss Sue M; de Koning Harry J; Auvinen Anssi;
Screening and prostate-cancer mortality in a randomized European study.
Draisma Gerrit; Etzioni Ruth; Tsodikov Alex; Mariotto Angela; Wever Elisabeth; Gulati Roman; Feuer Eric; de Koning Harry
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Harry de Koning (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: van den Bergh K A M; Essink-Bot M L; van Klaveren R J; de Koning H J
Informed participation in a randomised controlled trial of computed tomography screening for lung cancer.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2009;34(3):711-20.
2009: Schröder Fritz H; Hugosson Jonas; Roobol Monique J; Tammela Teuvo L J; Ciatto Stefano; Nelen Vera; Kwiatkowski Maciej; Lujan Marcos; Lilja Hans; Zappa Marco; Denis Louis J; Recker Franz; Berenguer Antonio; Määttänen Liisa; Bangma Chris H; Aus Gunnar; Villers Arnauld; Rebillard Xavier; van der Kwast Theodorus; Blijenberg Bert G; Moss Sue M; de Koning Harry J; Auvinen Anssi;
Screening and prostate-cancer mortality in a randomized European study.
The New England journal of medicine 2009;360(13):1320-8.
2009: Draisma Gerrit; Etzioni Ruth; Tsodikov Alex; Mariotto Angela; Wever Elisabeth; Gulati Roman; Feuer Eric; de Koning Harry
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
Journal of the National Cancer Institute 2009;101(6):374-83.
2009: Duijm Lucien E M; Groenewoud Johanna H; de Koning Harry J; Coebergh Jan Willem; van Beek Mike; Hooijen Marianne J H H; van de Poll-Franse Lonneke V
Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
European journal of cancer (Oxford, England : 1990) 2009;45(5):774-81.
2008: Bunge Eveline M; van den Bergh Karien A M; Essink-Bot Marie-Louise; van Klaveren Rob J; de Koning Harry J
High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):385-90.
2008: Duijm Lucien E M; Groenewoud Johanna H; Fracheboud Jacques; Plaisier Menno L; Roumen Rudi M H; van Ineveld B Martin; van Beek Mike; de Koning Harry J
Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005.
European radiology 2008;18(11):2390-7.
2008: Xu Dong Ming; van Klaveren Rob J; de Bock Geertruida H; Leusveld Anne; Zhao Yingru; Wang Ying; Vliegenthart Rozemarijn; de Koning Harry J; Scholten Ernst T; Verschakelen Johny; Prokop Mathias; Oudkerk Matthijs
Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial.
European journal of radiology 2008;68(2):347-52.
2008: Otten Johannes D M; Broeders Mireille J M; Fracheboud Jacques; Otto Suzie J; de Koning Harry J; Verbeek André L M
Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.
International journal of cancer. Journal international du cancer 2008;123(8):1929-34.
2008: Okonkwo Quirine Lamberts; Draisma Gerrit; der Kinderen Arno; Brown Martin L; de Koning Harry J
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Journal of the National Cancer Institute 2008;100(18):1290-300.
2008: Wang Ying; van Klaveren Rob J; van der Zaag-Loonen Hester J; de Bock Geertruida H; Gietema Hester A; Xu Dong Ming; Leusveld Anne L M; de Koning Harry J; Scholten Ernst T; Verschakelen Johny; Prokop Mathias; Oudkerk Matthijs
Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program.
Radiology 2008;248(2):625-31.
2008: de Gelder Rianne; van As Elisabeth; Tilanus-Linthorst Madeleine M A; Bartels Carina C M; Boer Rob; Draisma Gerrit; de Koning Harry J
Breast cancer screening: evidence for false reassurance?
International journal of cancer. Journal international du cancer 2008;123(3):680-6.
2008: van den Bergh Karien A M; Essink-Bot Marie-Louise; Bunge Eveline M; Scholten Ernst Th; Prokop Mathias; van Iersel Carola A; van Klaveren Rob J; de Koning Harry J
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial).
Cancer 2008;113(2):396-404.
2008: Korfage Ida J; Roobol Monique; de Koning Harry J; Kirkels Wim J; Schröder Fritz H; Essink-Bot Marie-Louise
Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.
Urology 2008;72(1):3-9.
2008: Duijm Lucien E M; Groenewoud Johanna H; Fracheboud Jacques; van Ineveld B Martin; Roumen Rudi M H; de Koning Harry J
Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome.
European journal of cancer (Oxford, England : 1990) 2008;44(9):1223-8.
2008: van't Westeinde Susan C; de Koning Harry J; Xu Dong-Ming; Hoogsteden Henk C; van Klaveren Rob J
How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):151-9.
2008: Bunge Eveline M; Juttmann Rikard E; van Biezen Frans C; Creemers Huub; Hazebroek-Kampschreur Alice A J M; Luttmer Bert C F; Wiegersma P Auke; de Koning Harry J;
Estimating the effectiveness of screening for scoliosis: a case-control study.
Pediatrics 2008;121(1):9-14.
2008: Bunge Eveline M; de Koning Harry J;
Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial.
BMC musculoskeletal disorders 2008;9():57.
2007: van Agt Heleen M E; van der Stege Heleen A; de Ridder-Sluiter Hanneke; Verhoeven Ludo T W; de Koning Harry J
A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8.
Pediatrics 2007;120(6):1317-25.
2007: Korfage Ida J; de Koning Harry J; Essink-Bot Marie-Louise
Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(10):1627-34.
2007: Mohangoo Ashna D; de Koning Harry J; Mangunkusumo Resiti T; Raat Hein
Health-related quality of life in adolescents with wheezing attacks.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2007;41(5):464-71.
2007: Duijm Lucien E M; Groenewoud Johanna H; Roumen Rudi M H; de Koning Harry J; Plaisier Menno L; Fracheboud Jacques
A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
Breast cancer research and treatment 2007;106(1):113-9.
2007: Pieterse K; van Dooren S; Seynaeve C; Bartels C C M; Rijnsburger A J; de Koning H J; Klijn J G M; van Elderen T; Tibben A; Duivenvoorden H J
Passive coping and psychological distress in women adhering to regular breast cancer surveillance.
Psycho-oncology 2007;16(9):851-8.
2007: Duijm Lucien E M; Groenewoud Johanna H; Fracheboud Jacques; de Koning Harry J
Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
Journal of the National Cancer Institute 2007;99(15):1162-70.
2007: Kriege M; Brekelmans C T M; Peterse H; Obdeijn I M; Boetes C; Zonderland H M; Muller S H; Kok T; Manoliu R A; Besnard A P E; Tilanus-Linthorst M M A; Seynaeve C; Bartels C C M; Meijer S; Oosterwijk J C; Hoogerbrugge N; Tollenaar R A E M; de Koning H J; Rutgers E J T; Klijn J G M
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
Breast cancer research and treatment 2007;102(3):357-63.
2007: Korfage Ida J; de Koning Harry J; Habbema J Dik F; Schröder Fritz H; Essink-Bot Marie-Louise
Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
BJU international 2007;99(4):801-6.
2007: Groenewoud J H; Otten J D M; Fracheboud J; Draisma G; van Ineveld B M; Holland R; Verbeek A L M; de Koning H J;
Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands.
Breast cancer research and treatment 2007;102(2):211-8.
2007: Mangunkusumo Resiti T; Brug Johannes; de Koning Harry J; van der Lei Johan; Raat Hein
School-based internet-tailored fruit and vegetable education combined with brief counselling increases children's awareness of intake levels.
Public health nutrition 2007;10(3):273-9.
2007: van Agt H M E; van der Stege H A; de Ridder-Sluiter J G; de Koning H J
Detecting language problems: accuracy of five language screening instruments in preschool children.
Developmental medicine and child neurology 2007;49(2):117-22; discussion 84.
2007: van Iersel Carola A; de Koning Harry J; Draisma Gerrit; Mali Willem P T M; Scholten Ernst Th; Nackaerts Kristiaan; Prokop Mathias; Habbema J Dik F; Oudkerk Mathijs; van Klaveren Rob J
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
International journal of cancer. Journal international du cancer 2007;120(4):868-74.
2007: de Vries Stijn H; Postma Renske; Raaijmakers René; Roemeling Stijn; Otto Suzie; de Koning Harry J; Schröder Fritz H
Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
European urology 2007;51(2):366-74; discussion 374.
2007: Steyerberg E W; Roobol M J; Kattan M W; van der Kwast T H; de Koning H J; Schröder F H
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
The Journal of urology 2007;177(1):107-12; discussion 112.
2007: Bunge Eveline M; Juttmann Rikard E; de Kleuver Marinus; van Biezen Frans C; de Koning Harry J;
Health-related quality of life in patients with adolescent idiopathic scoliosis after treatment: short-term effects after brace or surgical treatment.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2007;16(1):83-9.
2006: Draisma Gerrit; Postma Renske; Schröder Fritz H; van der Kwast Theo H; de Koning Harry J
Gleason score, age and screening: modeling dedifferentiation in prostate cancer.
International journal of cancer. Journal international du cancer 2006;119(10):2366-71.
2006: Kriege Mieke; Brekelmans Cecile T M; Obdeijn Inge Marie; Boetes Carla; Zonderland Harmine M; Muller Sara H; Kok Theo; Manoliu Radu A; Besnard A Peter E; Tilanus-Linthorst Madeleine M A; Seynaeve Caroline; Bartels Carina C M; Kaas Reini; Meijer Siebren; Oosterwijk Jan C; Hoogerbrugge Nicoline; Tollenaar Rob A E M; Rutgers Emiel J T; de Koning Harry J; Klijn Jan G M
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
Breast cancer research and treatment 2006;100(1):109-19.
2006: Essink-Bot M L; Rijnsburger A J; van Dooren S; de Koning H J; Seynaeve C
Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
Breast (Edinburgh, Scotland) 2006;15(5):673-6.
2006: Otto Suzie J; Schröder Fritz H; de Koning Harry J
Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4184-9.
2006: Korfage Ida Joanna; Hak Tony; de Koning Harry J; Essink-Bot Marie-Louise
Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study.
Social science & medicine (1982) 2006;63(4):911-9.
2006: Rijnsburger A J; Essink-Bot M L; van As E; Cockburn J; de Koning H J
Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(5):933-40.
2006: Kriege Mieke; Brekelmans Cecile T M; Boetes Carla; Muller Sara H; Zonderland Harmine M; Obdeijn Inge Marie; Manoliu Radu A; Kok Theo; Rutgers Emiel J T; de Koning Harry J; Klijn Jan G M;
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Cancer 2006;106(11):2318-26.
2006: Korfage I J; Essink-Bot M-L; Janssens A C J W; Schröder F H; de Koning H J
Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up.
British journal of cancer 2006;94(8):1093-8.
2006: Bunge Eveline M; de Koning Harry J
Selective screening for scoliosis.
Clinical orthopaedics and related research 2006;445():277-8; author reply 278-9.
2006: Fracheboud Jacques; Groenewoud Johanna Helëne; Boer Rob; Draisma Gerrit; de Bruijn Arry E; Verbeek André L M; de Koning Harry J
Seventy-five years is an appropriate upper age limit for population-based mammography screening.
International journal of cancer. Journal international du cancer 2006;118(8):2020-5.
2006: Mangunkusumo Resiti T; Duisterhout Joop S; de Graaff Nijs; Maarsingh Erik J; de Koning Harry J; Raat Hein
Internet versus paper mode of health and health behavior questionnaires in elementary schools: asthma and fruit as examples.
The Journal of school health 2006;76(2):80-6.
2006: Korfage Ida J; de Koning Harry J; Roobol Monique; Schröder Fritz H; Essink-Bot Marie-Louise
Prostate cancer diagnosis: the impact on patients' mental health.
European journal of cancer (Oxford, England : 1990) 2006;42(2):165-70.
2006: Tan Sita Y G L; van Oortmarssen Gerrit J; de Koning Harry J; Boer Rob; Habbema J Dik F
The MISCAN-Fadia continuous tumor growth model for breast cancer.
Journal of the National Cancer Institute. Monographs 2006;(36):56-65.
2006: Bunge Eveline M; Juttmann Rikard E; de Koning Harry J;
Screening for scoliosis: do we have indications for effectiveness?
Journal of medical screening 2006;13(1):29-33.
2006: de Koning Harry J; Draisma Gerrit; Fracheboud Jacques; de Bruijn Arry
Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
Breast cancer research : BCR 2006;8(1):202.
2005: Mohangoo Ashna D; Essink-Bot Marie-Louise; Juniper Elizabeth F; Moll Henriëtte A; de Koning Harry J; Raat Hein
Health-related quality of life in preschool children with wheezing and dyspnea: preliminary results from a random general population sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(8):1931-6.
2005: Korfage Ida J; Essink-Bot Marie-Louise; Borsboom Gerard J J M; Madalinska Joanna B; Kirkels Wim J; Habbema J Dik F; Schröder Fritz H; de Koning Harry J
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.
International journal of cancer. Journal international du cancer 2005;116(2):291-6.
2005: Tilanus-Linthorst Madeleine M A; Kriege Mieke; Boetes Carla; Hop Wim C J; Obdeijn Inge-Marie; Oosterwijk Jan C; Peterse Hans L; Zonderland Harmine M; Meijer Sybren; Eggermont Alexander M M; de Koning Harry J; Klijn Jan G M; Brekelmans Cecile T M
Hereditary breast cancer growth rates and its impact on screening policy.
European journal of cancer (Oxford, England : 1990) 2005;41(11):1610-7.
2005: van der Cruijsen-Koeter Ingrid W; Vis André N; Roobol Monique J; Wildhagen Mark F; de Koning Harry J; van der Kwast Theo H; Schröder Fritz H
Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.
The Journal of urology 2005;174(1):121-5.
2005: van Dooren Silvia; Seynaeve Caroline; Rijnsburger Adriana J; Duivenvoorden Hugo J; Essink-Bot Marie-Louise; Tilanus-Linthorst Madeleine M A; Klijn Jan G M; de Koning Harry J; Tibben Aad
Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(10):1416-25.
2005: van Agt Heleen M E; Essink-Bot Marie-Louise; van der Stege Heleen A; de Ridder-Sluiter J G; de Koning Harry J
Quality of life of children with language delays.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2005;14(5):1345-55.
2005: Otten Johannes D M; Karssemeijer Nico; Hendriks Jan H C L; Groenewoud Johanna H; Fracheboud Jacques; Verbeek André L M; de Koning Harry J; Holland Roland
Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Journal of the National Cancer Institute 2005;97(10):748-54.
2005: Schröder Fritz H; Roobol Monique J; Damhuis Ronald A M; de Koning Harry J; Blijenberg Bert G; Van der Kwast Theo H; Kirkels Wim J; Bangma Chris H
Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.
Journal of the National Cancer Institute 2005;97(9):696.
2005: de Koning Harry J
Errors in "family" practice.
Lancet 2005;365(9463):1001.
2005: van Dooren Silvia; Seynaeve Caroline; Rijnsburger Adriana J; Duivenvoorden Hugo J; Essink-Bot Marie-Louise; Bartels Carina C M; Klijn Jan G M; de Koning Harry J; Tibben Aad
The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer.
Breast cancer research and treatment 2005;89(1):75-80.
2005: Mangunkusumo Resiti T; Moorman Peter W; Van Den Berg-de Ruiter Annelette E; Van Der Lei Johan; De Koning Harry J; Raat Hein
Internet-administered adolescent health questionnaires compared with a paper version in a randomized study.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2005;36(1):70.e1-6.
2004: Duijm L E M; Groenewoud J H; Jansen F H; Fracheboud J; van Beek M; de Koning H J
Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening.
British journal of cancer 2004;91(10):1795-9.
2004: van Dooren Silvia; Rijnsburger Adriana J; Seynaeve Caroline; Duivenvoorden Hugo J; Essink-Bot Marie-Louise; Tilanus-Linthorst Madeleine M A; de Koning Harry J; Tibben Aad
Psychological distress in women at increased risk for breast cancer: the role of risk perception.
European journal of cancer (Oxford, England : 1990) 2004;40(14):2056-63.
2004: Fracheboud J; Otto S J; van Dijck J A A M; Broeders M J M; Verbeek A L M; de Koning H J;
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands.
British journal of cancer 2004;91(5):861-7.
2004: Kriege Mieke; Brekelmans Cecile T M; Boetes Carla; Besnard Peter E; Zonderland Harmine M; Obdeijn Inge Marie; Manoliu Radu A; Kok Theo; Peterse Hans; Tilanus-Linthorst Madeleine M A; Muller Sara H; Meijer Sybren; Oosterwijk Jan C; Beex Louk V A M; Tollenaar Rob A E M; de Koning Harry J; Rutgers Emiel J T; Klijn Jan G M;
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
The New England journal of medicine 2004;351(5):427-37.
2004: Vervoort M M; Draisma G; Fracheboud J; van de Poll-Franse L V; de Koning H J
Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.
British journal of cancer 2004;91(2):242-7.
2004: Rijnsburger A J; Essink-Bot M L; van Dooren S; Borsboom G J J M; Seynaeve C; Bartels C C M; Klijn J G M; Tibben A; de Koning H J
Impact of screening for breast cancer in high-risk women on health-related quality of life.
British journal of cancer 2004;91(1):69-76.
2004: Rijnsburger Adriana J; van Oortmarssen Gerrit J; Boer Rob; Draisma Gerrit; To Teresa; Miller Anthony B; de Koning Harry J
Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.
International journal of cancer. Journal international du cancer 2004;110(5):756-62.
2004: Otto Suzie J; de Koning Harry J
Update on screening and early detection of prostate cancer.
Current opinion in urology 2004;14(3):151-6.
2004: Duijm Lucien E M; Groenewoud Johanna H; Hendriks Jan H C L; de Koning Harry J
Independent double reading of screening mammograms in The Netherlands: effect of arbitration following reader disagreements.
Radiology 2004;231(2):564-70.
2004: Roobol M J; Kranse R; de Koning H J; Schröder F H
Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
Urology 2004;63(2):309-13; discussion 313-5.
2004: Groenewoud J H; Pijnappel R M; van den Akker-Van Marle M E; Birnie E; Buijs-van der Woude T; Mali W P Th M; de Koning H J; Buskens E
Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
British journal of cancer 2004;90(2):383-92.
2004: de Koning H J; de Ridder-Sluiter J G; van Agt H M E; Reep-van den Bergh C M M; van der Stege H A; Korfage I J; Polder J J; van der Maas P J
A cluster-randomised trial of screening for language disorders in toddlers.
Journal of medical screening 2004;11(3):109-16.
2004: Otto S J; Schröder F H; de Koning H J
Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
Journal of medical screening 2004;11(2):89-92.
2003: De Koning H J; Hakulinen T; Moss S M; Adolfsson J; Smith P H; Alexander F E;
Monitoring the ERSPC trial.
BJU international 2003;92 Suppl 2():112-4.
2003: Draisma G; De Koning H J
MISCAN: estimating lead-time and over-detection by simulation.
BJU international 2003;92 Suppl 2():106-11.
2003: Essink-Bot M L; Korfage I J; De Koning H J
Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
BJU international 2003;92 Suppl 2():101-5.
2003: De Koning H J; Blom J; Merkelbach J W; Raaijmakers R; Verhaegen H; Van Vliet P; Nelen V; Coebergh J W W; Hermans A; Ciatto S; Mäkinen T
Determining the cause of death in randomized screening trial(s) for prostate cancer.
BJU international 2003;92 Suppl 2():71-8.
2003: Draisma Gerrit; Boer Rob; Otto Suzie J; van der Cruijsen Ingrid W; Damhuis Ronald A M; Schröder Fritz H; de Koning Harry J
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
Journal of the National Cancer Institute 2003;95(12):868-78.
2003: Korfage I J; Essink-Bot M L; Madalinska J B; Kirkels W J; Litwin M S; de Koning H J
Measuring disease specific quality of life in localized prostate cancer: the Dutch experience.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):459-64.
2003: Otto Suzie J; van der Cruijsen Ingrid W; Liem Michael K; Korfage Ida J; Lous Jan J; Schröder Fritz H; de Koning Harry J
Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
International journal of cancer. Journal international du cancer 2003;105(3):394-9.
2003: Otto Suzie J; Fracheboud Jacques; Looman Caspar W N; Broeders Mireille J M; Boer Rob; Hendriks Jan H C L; Verbeek André L M; de Koning Harry J;
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.
Lancet 2003;361(9367):1411-7.
2003: Karssemeijer Nico; Otten Johannes D M; Verbeek Andre L M; Groenewoud Johanna H; de Koning Harry J; Hendriks Jan H C L; Holland Roland
Computer-aided detection versus independent double reading of masses on mammograms.
Radiology 2003;227(1):192-200.
2003: van Dooren S; Rijnsburger A J; Seynaeve C; Kriege A; Duivenvoorden H J; Bartels C C M; Essink-Bot M L; de Koning H J; Tibben A
Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer.
Community genetics 2003;6(4):235-41.
2002: van Klaveren Rob J; de Koning Harry J; Mulshine James; Hirsch Fred R
Lung cancer screening by spiral CT. What is the optimal target population for screening trials?
Lung cancer (Amsterdam, Netherlands) 2002;38(3):243-52.
2002: de Koning Harry J; Liem Michael K; Baan Caroline A; Boer Rob; Schröder Fritz H; Alexander Freda E;
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial.
International journal of cancer. Journal international du cancer 2002;98(2):268-73.
2002: de Koning Harry J; Auvinen Anssi; Berenguer Sanchez Antonio; Calais da Silva Fernando; Ciatto Stefano; Denis Louis; Gohagan John K; Hakama Matti; Hugosson Jonas; Kranse Ries; Nelen Vera; Prorok Philip C; Schröder Fritz H;
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
International journal of cancer. Journal international du cancer 2002;97(2):237-44.
2001: Miller A B; Madalinska J B; Church T; Crawford D; Essink-Bot M L; Goel V; de Koning H J; Määttänen L; Pentikäinen T
Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.
European journal of cancer (Oxford, England : 1990) 2001;37(17):2154-60.
2001: Van Der Cruijsen-Koeter I W; Wildhagen M F; De Koning H J; Schröder F H
The value of current diagnostic tests in prostate cancer screening.
BJU international 2001;88(5):458-66.
2001: Hoedemaeker R F; van der Kwast T H; Boer R; de Koning H J; Roobol M; Vis A N; Schröder F H
Pathologic features of prostate cancer found at population-based screening with a four-year interval.
Journal of the National Cancer Institute 2001;93(15):1153-8.
2001: Madalinska J B; Essink-Bot M L; de Koning H J; Kirkels W J; van der Maas P J; Schröder F H
Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1619-28.
2001: Fracheboud J; de Koning H J; Boer R; Groenewoud J H; Verbeek A L; Broeders M J; van Ineveld B M; Hendriks J H; de Bruyn A E; Holland R; van der Maas P J;
Nationwide breast cancer screening programme fully implemented in The Netherlands.
Breast (Edinburgh, Scotland) 2001;10(1):6-11.
2001: Madalinska J B; Essink-Bot M L; de Koning H J; Kirkels W J; van der Maas P J; Schröder F H
Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment.
The Prostate 2001;46(2):87-97.
2001: Kriege M; Brekelmans C T; Boetes C; Rutgers E J; Oosterwijk J C; Tollenaar R A; Manoliu R A; Holland R; de Koning H J; Klijn J G
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).
Familial cancer 2001;1(3-4):163-8.
2000: Beemsterboer P M; de Koning H J; Kranse R; Trienekens P H; van der Maas P J; Schröder F H
Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
The Journal of urology 2000;164(4):1216-20.
2000: Tilanus-Linthorst M M; Obdeijn I M; Bartels K C; de Koning H J; Oudkerk M
First experiences in screening women at high risk for breast cancer with MR imaging.
Breast cancer research and treatment 2000;63(1):53-60.
2000: Schröder F H; van der Cruijsen-Koeter I; de Koning H J; Vis A N; Hoedemaeker R F; Kranse R
Prostate cancer detection at low prostate specific antigen.
The Journal of urology 2000;163(3):806-12.
2000: de Koning H J
Assessment of nationwide cancer-screening programmes.
Lancet 2000;355(9198):80-1.
1999: Fracheboud J; de Koning H J; Beemsterboer P M; Boer R; Verbeek A L; Hendriks J H; van Ineveld B M; Broeders M J; de Bruyn A E; van der Maas P J
Interval cancers in the Dutch breast cancer screening programme.
British journal of cancer 1999;81(5):912-7.
1999: Boer R; de Koning H J; van der Maas P J
A longer breast carcinoma screening interval for women age older than 65 years?
Cancer 1999;86(8):1506-10.
1999: Beemsterboer P M; Kranse R; de Koning H J; Habbema J D; Schröder F H
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).
International journal of cancer. Journal international du cancer 1999;84(4):437-41.
1999: Beemsterboer P M; de Koning H J; Birnie E; van der Maas P J; Schröder F H
Advanced prostate cancer: course, care, and cost implications.
The Prostate 1999;40(2):97-104.
1999: Beemsterboer P M; de Koning H J; Looman C W; Borsboom G J; Bartelds A I; van der Maas P J
Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995.
European journal of cancer (Oxford, England : 1990) 1999;35(3):450-4.
1999: van Leiden H A; van Gessel-Dabekaussen A A; van der Maas P J; de Koning H J
Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.
Journal of medical screening 1999;6(2):94-8.
1998: Essink-Bot M L; de Koning H J; Nijs H G; Kirkels W J; van der Maas P J; Schröder F H
Short-term effects of population-based screening for prostate cancer on health-related quality of life.
Journal of the National Cancer Institute 1998;90(12):925-31.
1998: Fracheboud J; de Koning H J; Beemsterboer P M; Boer R; Hendriks J H; Verbeek A L; van Ineveld B M; de Bruyn A E; van der Maas P J
Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.
International journal of cancer. Journal international du cancer 1998;75(5):694-8.
1998: Beemsterboer P M; Warmerdam P G; Boer R; de Koning H J
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?
Journal of medical screening 1998;5(2):81-7.
1997: van den Akker-van Marle M E; Reep-van den Bergh C M; Boer R; Del Moral A; Ascunce N; de Koning H J
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
International journal of cancer. Journal international du cancer 1997;73(4):464-9.
1997: Boer R; de Koning H J; Beemsterboer P M; Warmerdam P G; Schroeder F H
A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.
The Journal of urology 1997;157(5):1768-71; discussion 1771-2.
1997: Warmerdam P G; de Koning H J; Boer R; Beemsterboer P M; Dierks M L; Swart E; Robra B P
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
Journal of epidemiology and community health 1997;51(2):180-6.
1996: de Koning H J; Coebergh J W; van Dongen J A
Is mass screening for breast cancer cost-effective?
European journal of cancer (Oxford, England : 1990) 1996;32A(11):1835-44.
1996: Juttmann R E; de Koning H J; Meulmeester J F; van der Maas P J
[Published effects of screening in parental and child health care]
Nederlands tijdschrift voor geneeskunde 1996;140(25):1303-7.
1996: Shröder F H; Damhuis R A; Kirkels W J; De Koning H J; Kranse R; Nus H G; Blijenberg B G
European randomized study of screening for prostate cancer--the Rotterdam pilot studies.
International journal of cancer. Journal international du cancer 1996;65(2):145-51.
1995: Boer R; de Koning H J; van Oortmarssen G J; van der Maas P J
In search of the best upper age limit for breast cancer screening.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):2040-3.
1995: de Koning H J; Boer R; Warmerdam P G; Beemsterboer P M; van der Maas P J
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
Journal of the National Cancer Institute 1995;87(16):1217-23.
1995: Schröder F H; Denis L J; Kirkels W; de Koning H J; Standaert B
European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.
Cancer 1995;76(1):129-34.
1995: De Koning H J; Fracheboud J; Boer R; Verbeek A L; Collette H J; Hendriks J H; van Ineveld B M; de Bruyn A E; van der Maas P J
Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
International journal of cancer. Journal international du cancer 1995;60(6):777-80.
1994: de Koning H J; van Dongen J A; van der Maas P J
Changes in use of breast-conserving therapy in years 1978-2000.
British journal of cancer 1994;70(6):1165-70.
1994: Beemsterboer P M; de Koning H J; Warmerdam P G; Boer R; Swart E; Dierks M L; Robra B P
Prediction of the effects and costs of breast-cancer screening in Germany.
International journal of cancer. Journal international du cancer 1994;58(5):623-8.
1993: Carter R; Glasziou P; van Oortmarssen G; de Koning H; Stevenson C; Salkeld G; Boer R
Cost-effectiveness of mammographic screening in Australia.
Australian journal of public health 1993;17(1):42-50.
1993: van Ineveld B M; van Oortmarssen G J; de Koning H J; Boer R; van der Maas P J
How cost-effective is breast cancer screening in different EC countries?
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1663-8.
1992: de Koning H J; van Ineveld B M; de Haes J C; van Oortmarssen G J; Klijn J G; van der Maas P J
Advanced breast cancer and its prevention by screening.
British journal of cancer 1992;65(6):950-5.
1991: de Haes J C; de Koning H J; van Oortmarssen G J; van Agt H M; de Bruyn A E; van Der Maas P J
The impact of a breast cancer screening programme on quality-adjusted life-years.
International journal of cancer. Journal international du cancer 1991;49(4):538-44.
1991: de Koning H J; van Ineveld B M; van Oortmarssen G J; de Haes J C; Collette H J; Hendriks J H; van der Maas P J
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.
International journal of cancer. Journal international du cancer 1991;49(4):531-7.
1990: de Koning H J; Boer R; van der Maas P J; van Ineveld B M; Collette H J; Hendriks J H
[Efficacy of mass screening for breast cancer; reduced mortality nationally and internationally]
Nederlands tijdschrift voor geneeskunde 1990;134(46):2240-5.
1990: van Oortmarssen G J; Habbema J D; van der Maas P J; de Koning H J; Collette H J; Verbeek A L; Geerts A T; Lubbe K T
A model for breast cancer screening.
Cancer 1990;66(7):1601-12.
1990: de Koning H J; van Oortmarssen G J; van Ineveld B M; van der Maas P J
Breast cancer screening: its impact on clinical medicine.
British journal of cancer 1990;61(2):292-7.
1989: van der Maas P J; de Koning H J; van Ineveld B M; van Oortmarssen G J; Habbema J D; Lubbe K T; Geerts A T; Collette H J; Verbeek A L; Hendriks J H
The cost-effectiveness of breast cancer screening.
International journal of cancer. Journal international du cancer 1989;43(6):1055-60.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Harry de Koning

Research Profile (preview)

Procedures

Geographic Areas

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Harry de Koning (preview)

All Publications